A case of advanced gastric cancer achieved a pathological complete response by chemotherapy

Surgical Case Reports

Table 1 Complete response rate in cases after chemotherapy for advanced or metastatic gastric cancer

First author	Year	Clinical trial	Regimen	Enrollment number	CR rate	MST
First author	Year	Clinical trial	Regimen	Enrollment number	(%)	(Month)
Unresectable stage
A Ohtsu [7]	2003	JCOG 9205	5-FU + CDDP	105	0	7.3
K Yamaguchi [9]	2006	–	S-1 + DTX	46	4.3	14
W Koizumi [4]	2008	SPIRITS trial	S-1 + CDDP	87	1.1	13
Bang Y J [16]	2010	ToGA trial	XP + trastuzumab	294	5.4	13.8
Resectable stage
T Yoshikawa [17]	2009	JCOG 0001	CPT-11 + CDDP	49	2.0^a	14.6
Y Iwasaki [18]	2013	JCOG 0210	S-1 + CDDP	47	2.1^a	17.3

MST median survival time, CDDP cisplatin, DTX docetaxel, CPT-11 irinotecan
^a pCR pathological complete response